Home > > > > Report Detail

Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines) Application (Research, Clinical, Cell Tissue & Banking), End User, Region( North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028

Publisher Name :
Date: 26-Jul-2023
No. of pages: 283
Inquire Before Buying

“Increasing demand for genetic diseases”

The stem cell manufacturing market is projected to reach USD 21.8 billion by 2028 from USD 12.7 billion in 2023, at a CAGR of 11.3% during the forecast period. The major factors driving the increasing prevalence of genetic diseases and increasing regulatory approvals on stem cell therapies are expected to propel the growth of the market. However, the high costs of research and manufacturing are expected to restrain market growth to a certain extent.

The stem cell manufacturing market has been segmented based on product, application, end-user, and region.

 “By-products, the consumables segment accounted for the largest share of the stem cell manufacturing market.”

Based on products, the stem cell manufacturing market is categorized into consumables, instruments, and stem cell lines. The consumables segment dominated the market in 2023, owing to rising demand for stem cell-based research, increasing government funding and initiatives, and the rising number of collaborations between academic institutions and pharmaceutical companies has led to a higher growth rate for products in the stem cell manufacturing market.

“By application, research application segment accounted for the largest share in the stem cell manufacturing market.”

Based on application, the stem cell manufacturing market is segmented into research applications, clinical applications, and cell & tissue banking applications. In 2023, the research application segment accounted for a larger share of the stem cell manufacturing market. Growth in this market segment can be attributed to a rising focus on stem cell cytology & pathophysiology research, growing awareness about the therapeutic potency of stem cells among researchers and healthcare professionals, growing public-private funding to support stem cell product development and commercialization, and technological advancements related to the effective production scale-up for stem cell products.

“North America: the largest share of the stem cell manufacturing market”

North America accounted for the largest share of the stem cell manufacturing market. The large share of the North American region can be attributed to a well-established healthcare and biotechnology industry in the region, with advanced infrastructure, cutting-edge research institutions, and a strong ecosystem of biotechnology companies and CROs specializing in stem cell research. The presence of top academic institutions and private companies in North America with dedicated stem cell research programs and expertise has contributed to the growth of the stem cell manufacturing market.

“Asia Pacific: The fastest-growing region in the stem cell manufacturing market.”

The Asia Pacific stem cell manufacturing market is projected to grow at the highest CAGR during the forecast period. This is attributed to the increasing demand for personalized medicine and advancements in stem cell-based therapies. Another key driver for the Asia Pacific stem cell manufacturing market is the region's large and rapidly increasing population.

The primary interviews conducted for this report can be categorized as follows:


  • By Respondent: Supply Side- 63% and Demand Side- 37%

  • By Designation: C Level Executives - 45%, Director Level- 30%, and Others - 25%

  • By Country: North America- 40%, Europe- 25%, Asia Pacific- 20%, Latin America - 10%, and Middle East Africa- 5%


Prominent  Players


  • Thermo Fisher Scientific, Inc. (US)

  • Merck KGaA (Germany)

  • Lonza Group (Switzerland)

  • Danaher Corporation (US)

  • Sartorius AG (Germany)

  • Becton, Dickinson, and Company (US)

  • Eppendorf AG (Germany)

  • Corning Inc. (US)

  • Bio-Rad Laboratories (US)

  • Takara Bio Group (Japan)

  • Fujifilm Holdings Corporation (Japan)

  • Getinge AB (Sweden)

  • Terumo Corporation (Japan)

  • Bio-Techne Corporation (US)

  • HiMedia Laboratories (India)

  • StemCell Technologies, Inc. (Canada)

  • Miltenyi Biotec GmBH (Germany)

  • PromoCell (Germany), Anterogen Co. Ltd. (South Korea)

  • CellGenix GmBH (India)

  • Pluristem Therapeutics Inc. (Israel)

  • Daiichi Sankyo (Japan)

  • Organogenesis Holdings Inc. (US)

  • Vericel Corporation (US)

  • American Cryostem Corporation (US)


Research Coverage:

This report provides a detailed picture of the stem cell manufacturing market. It aims at estimating the size and future growth potential of the market across different segments, such as the product (Consumables (culture media, and other consumables), instruments (Bioreactors & Incubators, cell sorters, and other instruments), and stem cell lines (hematopoietic stem cells, mesenchymal stem cells, induced pluripotent stem cells, embryonic stem cells, neural stem cells, and multipotent adult progenitor stem cells), application(research applications (life science research, and drug discovery and development), clinical applications (allogeneic stem cell therapy, and autologous stem cell therapy), and cell & tissue banking applications), and end-user (hospitals & surgical centers, pharmaceutical & biotechnology companies, cell & tissue banks, academic institutes, research laboratories, and CROs, and other end users) and region (North America, Europe, Asia Pacific, Latin America, and Middle East Africa). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall stem cell manufacturing market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

The report provides insights on the following pointers:


  • Analysis of key drivers (growing venture capital investments in stem cell research, increasing awareness about the therapeutic potency of stem cell products, and technological advancements in stem cell manufacturing), restraints (significant operational costs associated with stem cell manufacturing and banking), opportunities (development of new vaccine and treatment of genetic diseases in Asia Pacific region, government initiatives to boost the biotechnology and biopharmaceutical industries, and increased market focus on mesenchymal stem cells and induced pluripotent stem cells), and challenges (technical limitations associated with manufacturing scale-up, and socio-ethical concerns related to the use of allogeneic and human embryonic stem cells) influencing the growth of the stem cell manufacturing market.

  • Product Development/ Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the stem cell manufacturing market.

  • Market Development:  Comprehensive information about lucrative markets- the report analyses the stem cell manufacturing market across varied regions.

  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the stem cell manufacturing market.

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Merck KGaA (Germany), Lonza Group (Switzerland), and Danaher Corporation (US), among others, in the stem cell manufacturing market strategies. The report also helps stakeholders understand the pulse of the stem cell manufacturing market and provides them with information on key market drivers, restraints, challenges, and opportunities.

Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines) Application (Research, Clinical, Cell Tissue & Banking), End User, Region( North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028

Table Of Contents

1 Introduction 39
1.1 Study Objectives 39
1.2 Market Definition 39
1.2.1 Inclusions & Exclusions 40
1.3 Market Scope 40
1.3.1 Markets Covered 40
1.4 Years Considered 41
1.5 Currency 41
1.6 Research Limitations 41
1.7 Stakeholders 41
1.8 Summary Of Changes 42
1.9 Recession Impact 42

2 Research Methodology 43
2.1 Research Data 43
Figure 1 Stem Cell Manufacturing Market: Research Design 43
2.1.1 Secondary Data 44
2.1.2 Primary Data 45
Figure 2 Stem Cell Manufacturing Market: Breakdown Of Primaries 45
2.2 Market Estimation Methodology 46
Figure 3 Market Size Estimation: Approach 1 (Company Revenue Analysis-Based Estimation), 2022 46
Figure 4 Stem Cell Manufacturing Market Size (2022) 47
Figure 5 Stem Cell Manufacturing Market: Final Cagr Projections (2023−2028) 47
Figure 6 Stem Cell Manufacturing Market: Cagr Projections From Analysis Of Drivers, Restraints, Opportunities, And Challenges 48
2.3 Market Data Estimation And Triangulation 49
2.3.1 Data Triangulation 49
Figure 7 Data Triangulation Methodology 49
2.4 Industry Insights 50
2.5 Research Assumptions 50
2.6 Stem Cell Manufacturing Market: Global Recession Impact 51
Table 1 Global Inflation Rate Projections, 2021–2027 (% Growth) 51
Table 2 Us Health Expenditure, 2019–2022 (Usd Million) 51
Table 3 Us Health Expenditure, 2023–2027 (Usd Million) 51

3 Executive Summary 53
Figure 8 Stem Cell Manufacturing Market, By Product,
2023 Vs. 2028 (Usd Million) 53
Figure 9 Stem Cell Manufacturing Market, By Application,
2023 Vs. 2028 (Usd Million) 54
Figure 10 Stem Cell Manufacturing Market: Geographical Snapshot 55

4 Premium Insights 56
4.1 Stem Cell Manufacturing Market Overview 56
Figure 11 Growing Investments In Stem Cell-Based Research To Drive Market Growth 56
4.2 North America: Stem Cell Manufacturing Market, By Product And Country (2023) 57
Figure 12 Consumables To Account For Largest Market Share In 2023 57
4.3 Stem Cell Manufacturing Market, By End User (2023 Vs. 2028) 57
Figure 13 Pharmaceutical & Biotech Companies To Register Highest Growth During Forecast Period 57

5 Market Overview 58
5.1 Introduction 58
5.2 Market Dynamics 58
Figure 14 Stem Cell Manufacturing Market: Drivers, Restraints, Opportunities, And Challenges 58
Table 4 Stem Cell Manufacturing Market: Impact Analysis 59
5.2.1 Drivers 59
5.2.1.1 Growing Venture Capital Investments In Stem Cell Research 59
5.2.1.2 Increasing Awareness About Therapeutic Potency Of Stem Cell Products 60
5.2.1.3 Technological Advancements In Stem Cell Manufacturing 61
5.2.2 Restraints 61
5.2.2.1 Significant Operational Costs Associated With Stem Cell Manufacturing And Banking 61
5.2.3 Opportunities 62
5.2.3.1 Supportive Regulatory Framework Across Developing Economies 62
5.2.3.2 Government Initiatives To Boost Biotechnology And Biopharmaceutical Industries 62
5.2.3.3 Increased Market Focus On Mesenchymal Stem Cells And Induced Pluripotent Stem Cells 63
5.2.4 Challenges 64
5.2.4.1 Technical Limitations Associated With Manufacturing Scale-Up 64
5.2.4.2 Socio-Ethical Concerns Related To Use Of Allogeneic And Human Embryonic Stem Cells 64
5.3 Technology Analysis 65
Table 5 Single-Use Bioreactors Vs. Stainless Steel Bioreactors 65
5.4 Trends/Disruptions Impacting Customers’ Businesses 66
Figure 15 Trends/Disruptions Impacting Customers’ Businesses 66
5.5 Supply Chain Analysis 67
Figure 16 Stem Cell Manufacturing Market: Supply Chain Analysis 68
5.6 Value Chain Analysis 68
Figure 17 Stem Cell Manufacturing Market: Value Chain Analysis 69
5.7 Ecosystem Analysis 69
Figure 18 Stem Cell Manufacturing Market: Ecosystem Analysis 69
5.8 Porter’s Five Forces Analysis 70
Table 6 Stem Cell Manufacturing Market: Porter’s Five Forces Analysis 70
5.8.1 Intensity Of Competitive Rivalry 70
5.8.2 Bargaining Power Of Suppliers 70
5.8.3 Bargaining Power Of Buyers 70
5.8.4 Threat Of Substitutes 70
5.8.5 Threat Of New Entrants 71
5.9 Regulatory Analysis 71
5.9.1 Fda Approvals 71
5.9.2 Regulatory Bodies, Government Agencies, And Other Organizations 72
Table 7 North America: Regulatory Bodies, Government Agencies, And Other Organizations 72
Table 8 Europe: Regulatory Bodies, Government Agencies, And Other Organizations 73
Table 9 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations 74
Table 10 Latin America: Regulatory Bodies, Government Agencies, And Other Organizations 76
Table 11 Middle East & Africa: Regulatory Bodies, Government Agencies, And Other Organizations 76
5.10 Pricing Analysis 77
Table 12 Average Selling Price Of Products Offered By Key Players 77
5.10.1 Average Selling Price Trend Analysis 77
5.11 Patent Analysis 78
Figure 19 Granted Patents For Stem Cell Manufacturing, 2011–2023* 78
Table 13 Top Owners Of Stem Cell Manufacturing Patents 78
5.12 Key Conferences & Events In 2023–2024 79
Table 14 Stem Cell Manufacturing Conferences (2023–2024) 79
5.13 Key Stakeholders & Buying Criteria 80
5.13.1 Key Stakeholders In Buying Process 80
Figure 20 Stem Cell Manufacturing Market: Influence Of Stakeholders On Buying Process 80
5.13.2 Stem Cell Manufacturing Market: Buying Criteria 80
Figure 21 Key Buying Criteria For End Users 80

6 Stem Cell Manufacturing Market, By Product 81
6.1 Introduction 82
Table 15 Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 82
6.2 Consumables 82
Table 16 Stem Cell Manufacturing Market For Consumables, By Type,
2021–2028 (Usd Million) 83
Table 17 Stem Cell Manufacturing Market For Consumables, By Region, 2021–2028 (Usd Million) 83
Table 18 North America: Stem Cell Manufacturing Market For Consumables, By Country, 2021–2028 (Usd Million) 83
Table 19 Europe: Stem Cell Manufacturing Market For Consumables,
By Country, 2021–2028 (Usd Million) 84
Table 20 Asia Pacific: Stem Cell Manufacturing Market For Consumables, By Country, 2021–2028 (Usd Million) 84
6.2.1 Culture Media 84
6.2.1.1 Rising Stem Cell Research And Increasing Demand For Stem Cell Therapies To Boost Adoption Of Culture Media 84
Table 21 Stem Cell Manufacturing Market For Culture Media, By Region, 2021–2028 (Usd Million) 85
Table 22 North America: Stem Cell Manufacturing Market For Culture Media, By Country, 2021–2028 (Usd Million) 85
Table 23 Europe: Stem Cell Manufacturing Market For Culture Media, By Country, 2021–2028 (Usd Million) 86
Table 24 Asia Pacific: Stem Cell Manufacturing Market For Culture Media, By Country, 2021–2028 (Usd Million) 86
6.2.2 Other Consumables 86
Table 25 Stem Cell Manufacturing Market For Other Consumables, By Region, 2021–2028 (Usd Million) 87
Table 26 North America: Stem Cell Manufacturing Market For Other Consumables, By Country, 2021–2028 (Usd Million) 87
Table 27 Europe: Stem Cell Manufacturing Market For Other Consumables, By Country, 2021–2028 (Usd Million) 88
Table 28 Asia Pacific: Stem Cell Manufacturing Market For Other Consumables, By Country, 2021–2028 (Usd Million) 88
6.3 Instruments 88
Table 29 Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 89
Table 30 Stem Cell Manufacturing Market For Instruments, By Region, 2021–2028 (Usd Million) 89
Table 31 North America: Stem Cell Manufacturing Market For Instruments, By Country, 2021–2028 (Usd Million) 90
Table 32 Europe: Stem Cell Manufacturing Market For Instruments, By Country, 2021–2028 (Usd Million) 90
Table 33 Asia Pacific: Stem Cell Manufacturing Market For Instruments, By Country, 2021–2028 (Usd Million) 90
6.3.1 Bioreactors & Incubators 91
6.3.1.1 Introduction Of Advanced Bioreactors And Incubators To Contribute To Market Growth 91
Table 34 Stem Cell Manufacturing Market For Bioreactors & Incubators, By Region, 2021–2028 (Usd Million) 91
Table 35 North America: Stem Cell Manufacturing Market For Bioreactors & Incubators, By Country, 2021–2028 (Usd Million) 92
Table 36 Europe: Stem Cell Manufacturing Market For Bioreactors & Incubators, By Country, 2021–2028 (Usd Million) 92
Table 37 Asia Pacific: Stem Cell Manufacturing Market For Bioreactors & Incubators, By Country, 2021–2028 (Usd Million) 93
6.3.2 Cell Sorters 93
6.3.2.1 Development Of Novel Cell Sorting Technologies Such As Microfluidics To Drive Market 93
Table 38 Stem Cell Manufacturing Market For Cell Sorters, By Region, 2021–2028 (Usd Million) 94
Table 39 North America: Stem Cell Manufacturing Market For Cell Sorters, By Country, 2021–2028 (Usd Million) 94
Table 40 Europe: Stem Cell Manufacturing Market For Cell Sorters,
By Country, 2021–2028 (Usd Million) 95
Table 41 Asia Pacific: Stem Cell Manufacturing Market For Cell Sorters, By Country, 2021–2028 (Usd Million) 95
6.3.3 Other Instruments 96
Table 42 Stem Cell Manufacturing Market For Other Instruments,
By Region, 2021–2028 (Usd Million) 96
Table 43 North America: Stem Cell Manufacturing Market For Other Instruments, By Country, 2021–2028 (Usd Million) 96
Table 44 Europe: Stem Cell Manufacturing Market For Other Instruments, By Country, 2021–2028 (Usd Million) 97
Table 45 Asia Pacific: Stem Cell Manufacturing Market For Other Instruments, By Country, 2021–2028 (Usd Million) 97
6.4 Stem Cell Lines 97
Table 46 Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 98
Table 47 Stem Cell Manufacturing Market For Stem Cell Lines, By Region, 2021–2028 (Usd Million) 98
Table 48 North America: Stem Cell Manufacturing Market For Stem Cell Lines, By Country, 2021–2028 (Usd Million) 99
Table 49 Europe: Stem Cell Manufacturing Market For Stem Cell Lines,
By Country, 2021–2028 (Usd Million) 99
Table 50 Asia Pacific: Stem Cell Manufacturing Market For Stem Cell Lines, By Country, 2021–2028 (Usd Million) 100
6.4.1 Hematopoietic Stem Cells 100
6.4.1.1 Increasing Adoption Of Cord Blood Banking To Boost Market 100
Table 51 Stem Cell Manufacturing Market For Hematopoietic Stem Cells, By Region, 2021–2028 (Usd Million) 101
Table 52 North America: Stem Cell Manufacturing Market For Hematopoietic Stem Cells, By Country, 2021–2028 (Usd Million) 101
Table 53 Europe: Stem Cell Manufacturing Market For Hematopoietic Stem Cells, By Country, 2021–2028 (Usd Million) 102
Table 54 Asia Pacific: Stem Cell Manufacturing Market For Hematopoietic Stem Cells, By Country, 2021–2028 (Usd Million) 102
6.4.2 Mesenchymal Stem Cells 102
6.4.2.1 Ease Of Cell Harvesting, Processing, And Preservation To Drive Adoption Of Mscs 102
Table 55 Stem Cell Manufacturing Market For Mesenchymal Stem Cells,
By Region, 2021–2028 (Usd Million) 103
Table 56 North America: Stem Cell Manufacturing Market For Mesenchymal Stem Cells, By Country, 2021–2028 (Usd Million) 103
Table 57 Europe: Stem Cell Manufacturing Market For Mesenchymal Stem Cells, By Country, 2021–2028 (Usd Million) 104
Table 58 Asia Pacific: Stem Cell Manufacturing Market For Mesenchymal Stem Cells, By Country, 2021–2028 (Usd Million) 104
6.4.3 Induced Pluripotent Stem Cells 105
6.4.3.1 Increased Adoption Of Ipscs In Research On Cell Therapies & Regenerative Medicine To Fuel Growth 105
Table 59 Stem Cell Manufacturing Market For Induced Pluripotent Stem Cells, By Region, 2021–2028 (Usd Million) 105
Table 60 North America: Stem Cell Manufacturing Market For Induced Pluripotent Stem Cells, By Country, 2021–2028 (Usd Million) 106
Table 61 Europe: Stem Cell Manufacturing Market For Induced Pluripotent Stem Cells, By Country, 2021–2028 (Usd Million) 106
Table 62 Asia Pacific: Stem Cell Manufacturing Market For Induced Pluripotent Stem Cells, By Country, 2021–2028 (Usd Million) 107
6.4.4 Embryonic Stem Cells 107
6.4.4.1 Rising Research Activity In Cancer Precision Medicine To Contribute To Segmental Growth 107
Table 63 Stem Cell Manufacturing Market For Embryonic Stem Cells,
By Region, 2021–2028 (Usd Million) 108
Table 64 North America: Stem Cell Manufacturing Market For Embryonic Stem Cells, By Country, 2021–2028 (Usd Million) 108
Table 65 Europe: Stem Cell Manufacturing Market For Embryonic Stem Cells, By Country, 2021–2028 (Usd Million) 109
Table 66 Asia Pacific: Stem Cell Manufacturing Market For Embryonic Stem Cells, By Country, 2021–2028 (Usd Million) 109
6.4.5 Neural Stem Cells 110
6.4.5.1 Introduction Of Novel Isolation And Expansion Techniques For Nscs To Drive Market 110
Table 67 Stem Cell Manufacturing Market For Neural Stem Cells,
By Region, 2021–2028 (Usd Million) 110
Table 68 North America: Stem Cell Manufacturing Market For Neural Stem Cells, By Country, 2021–2028 (Usd Million) 110
Table 69 Europe: Stem Cell Manufacturing Market For Neural Stem Cells, By Country, 2021–2028 (Usd Million) 111
Table 70 Asia Pacific: Stem Cell Manufacturing Market For Neural Stem Cells, By Country, 2021–2028 (Usd Million) 111
6.4.6 Multipotent Adult Progenitor Stem Cells 111
6.4.6.1 Rising Awareness Of Role Of Mapcs In Research To Propel Market 111
Table 71 Stem Cell Manufacturing Market For Multipotent Adult Progenitor Stem Cells, By Region, 2021–2028 (Usd Million) 112
Table 72 North America: Stem Cell Manufacturing Market For Multipotent Adult Progenitor Stem Cells, By Country, 2021–2028 (Usd Million) 112
Table 73 Europe: Stem Cell Manufacturing Market For Multipotent Adult Progenitor Stem Cells, By Country, 2021–2028 (Usd Million) 113
Table 74 Asia Pacific: Stem Cell Manufacturing Market For Multipotent Adult Progenitor Stem Cells, By Country, 2021–2028 (Usd Million) 113

7 Stem Cell Manufacturing Market, By Application 114
7.1 Introduction 115
Table 75 Stem Cell Manufacturing Market, By Application, 2021–2028 (Usd Million) 115
7.2 Research Applications 116
Table 76 Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 116
Table 77 Stem Cell Manufacturing Market For Research Applications, By Region, 2021–2028 (Usd Million) 117
Table 78 North America: Stem Cell Manufacturing Market For Research Applications, By Country, 2021–2028 (Usd Million) 117
Table 79 Europe: Stem Cell Manufacturing Market For Research Applications, By Country, 2021–2028 (Usd Million) 118
Table 80 Asia Pacific: Stem Cell Manufacturing Market For Research Applications, By Country, 2021–2028 (Usd Million) 118
7.2.1 Life Science Research 118
7.2.1.1 Increasing Research Focus On Stem Cell Cytology & Pathology To Boost Market 118
Table 81 Stem Cell Manufacturing Market For Life Science Research, By Region, 2021–2028 (Usd Million) 119
Table 82 North America: Stem Cell Manufacturing Market For Life Science Research, By Country, 2021–2028 (Usd Million) 119
Table 83 Europe: Stem Cell Manufacturing Market For Life Science Research, By Country, 2021–2028 (Usd Million) 120
Table 84 Asia Pacific: Stem Cell Manufacturing Market For Life Science Research, By Country, 2021–2028 (Usd Million) 120
7.2.2 Drug Discovery & Development 120
7.2.2.1 Increasing Research Expenditure By Pharma And Biotech Companies To Contribute To Market Growth 120
Table 85 Stem Cell Manufacturing Market For Drug Discovery & Development, By Region, 2021–2028 (Usd Million) 121
Table 86 North America: Stem Cell Manufacturing Market For Drug Discovery & Development, By Country, 2021–2028 (Usd Million) 122
Table 87 Europe: Stem Cell Manufacturing Market For Drug Discovery & Development, By Country, 2021–2028 (Usd Million) 122
Table 88 Asia Pacific: Stem Cell Manufacturing Market For Drug Discovery & Development, By Country, 2021–2028 (Usd Million) 123
7.3 Clinical Applications 123
Table 89 Stem Cell Manufacturing Market For Clinical Applications,  By Type, 2021–2028 (Usd Million) 123
Table 90 Stem Cell Manufacturing Market For Clinical Applications,
By Region, 2021–2028 (Usd Million) 124
Table 91 North America: Stem Cell Manufacturing Market For Clinical Applications, By Country, 2021–2028 (Usd Million) 124
Table 92 Europe: Stem Cell Manufacturing Market For Clinical Applications, By Country, 2021–2028 (Usd Million) 125
Table 93 Asia Pacific: Stem Cell Manufacturing Market For Clinical Applications, By Country, 2021–2028 (Usd Million) 125
7.3.1 Allogeneic Stem Cell Therapy 125
7.3.1.1 Wide Therapeutic Applications Of Stem Cell Lines To Drive Growth 125
Table 94 Stem Cell Manufacturing Market For Allogeneic Stem Cell Therapy, By Region, 2021–2028 (Usd Million) 126
Table 95 North America: Stem Cell Manufacturing Market For Allogeneic Stem Cell Therapy, By Country, 2021–2028 (Usd Million) 126
Table 96 Europe: Stem Cell Manufacturing Market For Allogeneic Stem Cell Therapy, By Country, 2021–2028 (Usd Million) 127
Table 97 Asia Pacific: Stem Cell Manufacturing Market For Allogeneic Stem Cell Therapy, By Country, 2021–2028 (Usd Million) 127
7.3.2 Autologous Stem Cell Therapy 127
7.3.2.1 Increasing Patient Preference For Autologous Stem Cell Therapy To Drive Segmental Growth 127
Table 98 Stem Cell Manufacturing Market For Autologous Stem Cell Therapy, By Region, 2021–2028 (Usd Million) 128
Table 99 North America: Stem Cell Manufacturing Market For Autologous Stem Cell Therapy, By Country, 2021–2028 (Usd Million) 128
Table 100 Europe: Stem Cell Manufacturing Market For Autologous Stem Cell Therapy, By Country, 2021–2028 (Usd Million) 129
Table 101 Asia Pacific: Stem Cell Manufacturing Market For Autologous Stem Cell Therapy, By Country, 2021–2028 (Usd Million) 129
7.4 Cell & Tissue Banking Applications 129
7.4.1 Rising Demand For Cord Blood Stem Cell Banking To Favor Market Growth 129
Table 102 Stem Cell Manufacturing Market For Cell & Tissue Banking Applications, By Region, 2021–2028 (Usd Million) 130
Table 103 North America: Stem Cell Manufacturing Market For Cell & Tissue Banking Applications, By Country, 2021–2028 (Usd Million) 130
Table 104 Europe: Stem Cell Manufacturing Market For Cell & Tissue Banking Applications, By Country, 2021–2028 (Usd Million) 131
Table 105 Asia Pacific: Stem Cell Manufacturing Market For Cell & Tissue Banking Applications, By Country, 2021–2028 (Usd Million) 131

8 Stem Cell Manufacturing Market, By End User 132
8.1 Introduction 133
Table 106 Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 133
8.2 Pharmaceutical & Biotechnology Companies 134
8.2.1 Increasing Private Investments For Stem Cell-Based Research To Drive Market Growth 134
Table 107 Stem Cell Manufacturing Market For Pharmaceutical & Biotechnology Companies, By Region, 2021–2028 (Usd Million) 134
Table 108 North America: Stem Cell Manufacturing Market For Pharmaceutical & Biotechnology Companies, By Country,
2021–2028 (Usd Million) 135
Table 109 Europe: Stem Cell Manufacturing Market For Pharmaceutical & Biotechnology Companies, By Country, 2021–2028 (Usd Million) 135
Table 110 Asia Pacific: Stem Cell Manufacturing Market For Pharmaceutical & Biotechnology Companies, By Country, 2021–2028 (Usd Million) 136
8.3 Academic Institutes, Research Laboratories, And Contract Research Organizations 136
8.3.1 Increased Public Funding For Research Activities To Boost Market 136
Table 111 Stem Cell Manufacturing Market For Academic Institutes, Research Laboratories, And Cros, By Region,
2021–2028 (Usd Million) 137
Table 112 North America: Stem Cell Manufacturing Market For Academic Institutes, Research Laboratories, And Cros, By Country,
2021–2028 (Usd Million) 137
Table 113 Europe: Stem Cell Manufacturing Market For Academic Institutes, Research Laboratories, And Cros, By Country,
2021–2028 (Usd Million) 138
Table 114 Asia Pacific: Stem Cell Manufacturing Market For Academic Institutes, Research Laboratories, And Cros, By Country,
2021–2028 (Usd Million) 138
8.4 Hospitals & Surgical Centers 138
8.4.1 Improved Healthcare Infrastructure To Propel Growth 138
Table 115 Stem Cell Manufacturing Market For Hospitals & Surgical Centers, By Region, 2021–2028 (Usd Million) 139
Table 116 North America: Stem Cell Manufacturing Market For Hospitals & Surgical Centers, By Country, 2021–2028 (Usd Million) 139
Table 117 Europe: Stem Cell Manufacturing Market For Hospitals & Surgical Centers, By Country, 2021–2028 (Usd Million) 140
Table 118 Asia Pacific: Stem Cell Manufacturing Market For Hospitals & Surgical Centers, By Country, 2021–2028 (Usd Million) 140
8.5 Cell & Tissue Banks 140
8.5.1 Growing Application Of Stem Cells In Disease Treatment To Favor Market Growth 140
Table 119 Stem Cell Manufacturing Market For Cell & Tissue Banks, By Region, 2021–2028 (Usd Million) 141
Table 120 North America: Stem Cell Manufacturing Market For Cell & Tissue Banks, By Country, 2021–2028 (Usd Million) 141
Table 121 Europe: Stem Cell Manufacturing Market For Cell & Tissue Banks, By Country, 2021–2028 (Usd Million) 142
Table 122 Asia Pacific: Stem Cell Manufacturing Market For Cell & Tissue Banks, By Country, 2021–2028 (Usd Million) 142
8.6 Other End Users 143
Table 123 Stem Cell Manufacturing Market For Other End Users, By Region, 2021–2028 (Usd Million) 143
Table 124 North America: Stem Cell Manufacturing Market For Other End Users, By Country, 2021–2028 (Usd Million) 143
Table 125 Europe: Stem Cell Manufacturing Market For Other End Users,
By Country, 2021–2028 (Usd Million) 144
Table 126 Asia Pacific: Stem Cell Manufacturing Market For Other End Users, By Country, 2021–2028 (Usd Million) 144

9 Stem Cell Manufacturing Market, By Region 145
9.1 Introduction 146
Table 127 Stem Cell Manufacturing Market, By Region,
2021–2028 (Usd Million) 146
9.2 North America 146
Figure 22 North America: Stem Cell Manufacturing Market Snapshot 147
Table 128 North America: Stem Cell Manufacturing Market, By Country, 2021–2028 (Usd Million) 147
Table 129 North America: Stem Cell Manufacturing Market, By Product, 2021–2028 (Usd Million) 148
Table 130 North America: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 148
Table 131 North America: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 148
Table 132 North America: Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 149
Table 133 North America: Stem Cell Manufacturing Market, By Application, 2021–2028 (Usd Million) 149
Table 134 North America: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 150
Table 135 North America: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 150
Table 136 North America: Stem Cell Manufacturing Market, By End User, 2021–2028 (Usd Million) 151
9.2.1 Us 151
9.2.1.1 Continued Focus To Strengthen R&D To Drive Market In Us 151
Table 137 Us: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 152
Table 138 Us: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 153
Table 139 Us: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 153
Table 140 Us: Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 154
Table 141 Us: Stem Cell Manufacturing Market, By Application,
2021–2028 (Usd Million) 154
Table 142 Us: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 155
Table 143 Us: Stem Cell Manufacturing Market For Clinical Applications,
By Type, 2021–2028 (Usd Million) 155
Table 144 Us: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 156
9.2.2 Canada 156
9.2.2.1 Rising Government Investments To Drive Market In Canada 156
Table 145 Canada: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 157
Table 146 Canada: Stem Cell Manufacturing Market For Consumables,
By Type, 2021–2028 (Usd Million) 157
Table 147 Canada: Stem Cell Manufacturing Market For Instruments,
By Type, 2021–2028 (Usd Million) 157
Table 148 Canada: Stem Cell Manufacturing Market For Stem Cell Lines,
By Type, 2021–2028 (Usd Million) 158
Table 149 Canada: Stem Cell Manufacturing Market, By Application,
2021–2028 (Usd Million) 158
Table 150 Canada: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 159
Table 151 Canada: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 159
Table 152 Canada: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 160
9.2.3 North America: Impact Of Recession 160
9.3 Europe 161
Table 153 Europe: Stem Cell Manufacturing Market, By Country,
2021–2028 (Usd Million) 161
Table 154 Europe: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 162
Table 155 Europe: Stem Cell Manufacturing Market For Consumables,
By Type, 2021–2028 (Usd Million) 162
Table 156 Europe: Stem Cell Manufacturing Market For Instruments,
By Type, 2021–2028 (Usd Million) 162
Table 157 Europe: Stem Cell Manufacturing Market For Stem Cell Lines,
By Type, 2021–2028 (Usd Million) 163
Table 158 Europe: Stem Cell Manufacturing Market, By Application,
2021–2028 (Usd Million) 163
Table 159 Europe: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 164
Table 160 Europe: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 164
Table 161 Europe: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 165
9.3.1 Germany 165
9.3.1.1 Strong Growth In Biotechnology Industry To Drive Market 165
Table 162 Germany: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 166
Table 163 Germany: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 166
Table 164 Germany: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 166
Table 165 Germany: Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 167
Table 166 Germany: Stem Cell Manufacturing Market, By Application, 2021–2028 (Usd Million) 167
Table 167 Germany: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 168
Table 168 Germany: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 168
Table 169 Germany: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 169
9.3.2 France 169
9.3.2.1 Government Support In Stem Cell Manufacturing To Drive Market 169
Table 170 France: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 170
Table 171 France: Stem Cell Manufacturing Market For Consumables,
By Type, 2021–2028 (Usd Million) 170
Table 172 France: Stem Cell Manufacturing Market For Instruments,
By Type, 2021–2028 (Usd Million) 170
Table 173 France: Stem Cell Manufacturing Market For Stem Cell Lines,
By Type, 2021–2028 (Usd Million) 171
Table 174 France: Stem Cell Manufacturing Market, By Application,
2021–2028 (Usd Million) 171
Table 175 France: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 172
Table 176 France: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 172
Table 177 France: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 173
9.3.3 Uk 173
9.3.3.1 Growing Focus On Innovation To Increase Demand For Stem Cell-Based Therapeutics 173
Table 178 Uk: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 174
Table 179 Uk: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 174
Table 180 Uk: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 174
Table 181 Uk: Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 175
Table 182 Uk: Stem Cell Manufacturing Market, By Application,
2021–2028 (Usd Million) 175
Table 183 Uk: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 176
Table 184 Uk: Stem Cell Manufacturing Market For Clinical Applications,
By Type, 2021–2028 (Usd Million) 176
Table 185 Uk: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 177
9.3.4 Italy 177
9.3.4.1 Initiatives Encouraging Development Of Cell & Gene Therapy To Boost Demand For Stem Cell Manufacturing 177
Table 186 Italy: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 178
Table 187 Italy: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 178
Table 188 Italy: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 178
Table 189 Italy: Stem Cell Manufacturing Market For Stem Cell Lines,
By Type, 2021–2028 (Usd Million) 179
Table 190 Italy: Stem Cell Manufacturing Market, By Application,
2021–2028 (Usd Million) 179
Table 191 Italy: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 180
Table 192 Italy: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 180
Table 193 Italy: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 181
9.3.5 Spain 181
9.3.5.1 Increasing Demand For Precision Medicine To Drive Growth 181
Table 194 Spain: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 182
Table 195 Spain: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 182
Table 196 Spain: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 182
Table 197 Spain: Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 183
Table 198 Spain: Stem Cell Manufacturing Market, By Application,
2021–2028 (Usd Million) 183
Table 199 Spain: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 184
Table 200 Spain: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 184
Table 201 Spain: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 185
9.3.6 Rest Of Europe 185
Table 202 Rest Of Europe: Stem Cell Manufacturing Market, By Product, 2021–2028 (Usd Million) 186
Table 203 Rest Of Europe: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 186
Table 204 Rest Of Europe: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 187
Table 205 Rest Of Europe: Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 187
Table 206 Rest Of Europe: Stem Cell Manufacturing Market, By Application, 2021–2028 (Usd Million) 188
Table 207 Rest Of Europe: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 188
Table 208 Rest Of Europe: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 188
Table 209 Rest Of Europe: Stem Cell Manufacturing Market, By End User, 2021–2028 (Usd Million) 189
9.3.7 Europe: Impact Of Recession 189
9.4 Asia Pacific 189
Figure 23 Asia Pacific: Stem Cell Manufacturing Market Snapshot 190
Table 210 Asia Pacific: Stem Cell Manufacturing Market, By Country,
2021–2028 (Usd Million) 191
Table 211 Asia Pacific: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 191
Table 212 Asia Pacific: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 191
Table 213 Asia Pacific: Stem Cell Manufacturing Market For Instruments,
By Type, 2021–2028 (Usd Million) 192
Table 214 Asia Pacific: Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 192
Table 215 Asia Pacific: Stem Cell Manufacturing Market, By Application, 2021–2028 (Usd Million) 193
Table 216 Asia Pacific: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 193
Table 217 Asia Pacific: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 193
Table 218 Asia Pacific: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 194
9.4.1 China 194
9.4.1.1 Increasing Clinical Trials For Stem Cells And Innovations To Drive Market 194
Table 219 China: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 195
Table 220 China: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 195
Table 221 China: Stem Cell Manufacturing Market For Instruments,
By Type, 2021–2028 (Usd Million) 195
Table 222 China: Stem Cell Manufacturing Market For Stem Cell Lines,
By Type, 2021–2028 (Usd Million) 196
Table 223 China: Stem Cell Manufacturing Market, By Application,
2021–2028 (Usd Million) 196
Table 224 China: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 197
Table 225 China: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 197
Table 226 China: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 198
9.4.2 Japan 198
9.4.2.1 Growing Collaborations For Stem Cell Research To Drive Growth 198
Table 227 Japan: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 199
Table 228 Japan: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 199
Table 229 Japan: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 199
Table 230 Japan: Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 200
Table 231 Japan: Stem Cell Manufacturing Market, By Application,
2021–2028 (Usd Million) 200
Table 232 Japan: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 201
Table 233 Japan: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 201
Table 234 Japan: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 202
9.4.3 India 202
9.4.3.1 Increasing Prevalence Of Genetic Disorders To Support Growth 202
Table 235 India: Stem Cell Manufacturing Market, By Product,
2021–2028 (Usd Million) 203
Table 236 India: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 203
Table 237 India: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 203
Table 238 India: Stem Cell Manufacturing Market For Stem Cell Lines,
By Type, 2021–2028 (Usd Million) 204
Table 239 India: Stem Cell Manufacturing Market, By Application,
2021–2028 (Usd Million) 204
Table 240 India: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 205
Table 241 India: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 205
Table 242 India: Stem Cell Manufacturing Market, By End User,
2021–2028 (Usd Million) 206
9.4.4 Rest Of Asia Pacific 206
Table 243 Rest Of Asia Pacific: Stem Cell Manufacturing Market, By Product, 2021–2028 (Usd Million) 207
Table 244 Rest Of Asia Pacific: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 207
Table 245 Rest Of Asia Pacific: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 207
Table 246 Rest Of Asia Pacific: Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 208
Table 247 Rest Of Asia Pacific: Stem Cell Manufacturing Market,
By Application, 2021–2028 (Usd Million) 208
Table 248 Rest Of Asia Pacific: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 209
Table 249 Rest Of Asia Pacific: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 209
Table 250 Rest Of Asia Pacific: Stem Cell Manufacturing Market, By End User, 2021–2028 (Usd Million) 210
9.4.5 Asia Pacific: Impact Of Recession 210
9.5 Latin America 211
9.5.1 Growing Pharmaceutical Industry In Region To Drive Market Growth 211
Table 251 Latin America: Stem Cell Manufacturing Market, By Product, 2021–2028 (Usd Million) 211
Table 252 Latin America: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 211
Table 253 Latin America: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 212
Table 254 Latin America: Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 212
Table 255 Latin America: Stem Cell Manufacturing Market, By Application, 2021–2028 (Usd Million) 213
Table 256 Latin America: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 213
Table 257 Latin America: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 213
Table 258 Latin America: Stem Cell Manufacturing Market, By End User, 2021–2028 (Usd Million) 214
9.5.2 Latin America: Impact Of Recession 214
9.6 Middle East & Africa 214
9.6.1 Increasing Funding And Collaborations To Drive Market Growth 214
Table 259 Middle East & Africa: Stem Cell Manufacturing Market, By Product, 2021–2028 (Usd Million) 215
Table 260 Middle East & Africa: Stem Cell Manufacturing Market For Consumables, By Type, 2021–2028 (Usd Million) 215
Table 261 Middle East & Africa: Stem Cell Manufacturing Market For Instruments, By Type, 2021–2028 (Usd Million) 215
Table 262 Middle East & Africa: Stem Cell Manufacturing Market For Stem Cell Lines, By Type, 2021–2028 (Usd Million) 216
Table 263 Middle East & Africa: Stem Cell Manufacturing Market, By Application, 2021–2028 (Usd Million) 216
Table 264 Middle East & Africa: Stem Cell Manufacturing Market For Research Applications, By Type, 2021–2028 (Usd Million) 217
Table 265 Middle East & Africa: Stem Cell Manufacturing Market For Clinical Applications, By Type, 2021–2028 (Usd Million) 217
Table 266 Middle East & Africa: Stem Cell Manufacturing Market, By End User, 2021–2028 (Usd Million) 218
9.6.2 Middle East & Africa: Impact Of Recession 218

10 Competitive Landscape 219
10.1 Introduction 219
10.2 Key Strategies Adopted By Players 219
Figure 24 Stem Cell Manufacturing Market: Strategies Adopted By Key Players 220
10.3 Revenue Share Analysis Of Top 5 Players 221
Figure 25 Revenue Share Analysis For Top 5 Companies (2020−2022) 221
10.4 Market Share Analysis Of Top 5 Players 222
Figure 26 Stem Cell Manufacturing Market: Market Share Analysis Of Top 5 Players (2022) 222
10.5 Company Evaluation Quadrant For Key Players 224
Figure 27 Stem Cell Manufacturing Market: Company Evaluation Matrix For Key Players (2022) 225
10.5.1 Stars 225
10.5.2 Emerging Leaders 225
10.5.3 Pervasive Players 226
10.5.4 Participants 226
10.6 Company Evaluation Quadrant For Start-Ups/Smes 226
10.6.1 Progressive Companies 226
10.6.2 Starting Blocks 226
10.6.3 Responsive Companies 226
10.6.4 Dynamic Companies 227
Figure 28 Stem Cell Manufacturing Market: Company Evaluation Matrix For Start-Ups/Smes (2022) 227
10.7 Competitive Benchmarking 228
10.7.1 Stem Cell Manufacturing Market: Detailed List Of Start-Ups/Smes 228
Table 267 Stem Cell Manufacturing Market: Detailed List Of Start-Ups/Smes 228
10.8 Stem Cell Manufacturing Market: Competitive Benchmarking Of Start-Ups/Smes 229
Table 268 Stem Cell Manufacturing Market: Competitive Benchmarking Of Start-Ups/Smes 229
10.9 Competitive Scenario And Trends 230
Table 269 Stem Cell Manufacturing Market: Product Launches (2021–2023) 230
Table 270 Stem Cell Manufacturing Market: Deals (2021–2023) 230
Table 271 Stem Cell Manufacturing Market: Other Developments (2021–2023) 232

11 Company Profiles 233
11.1 Key Players 233
*Details On Business Overview, Products Offered, Recent Developments, And Mnm View (Key Strengths/Right To Win, Strategic Choices Made, And Weaknesses And Competitive Threats) Might Not Be Captured In Case Of Unlisted Companies.
11.1.1 Thermo Fisher Scientific, Inc. 233
Table 272 Thermo Fisher Scientific, Inc.: Company Overview 233
Figure 29 Thermo Fisher Scientific, Inc.: Company Snapshot (2022) 234
11.1.2 Merck Kgaa 240
Table 273 Merck Kgaa: Company Overview 240
Figure 30 Merck Kgaa: Company Snapshot (2022) 241
11.1.3 Lonza Group 246
Table 274 Lonza Group: Company Overview 246
Figure 31 Lonza Group: Company Snapshot (2022) 247
11.1.4 Danaher Corporation 254
Table 275 Danaher Corporation: Company Overview 254
Figure 32 Danaher Corporation: Company Snapshot (2022) 255
11.1.5 Sartorius Ag 259
Table 276 Sartorius Ag: Company Overview 259
Figure 33 Sartorius Ag: Company Snapshot (2022) 260
11.1.6 Becton, Dickinson And Company 264
Table 277 Becton, Dickinson And Company: Company Overview 264
Figure 34 Becton, Dickinson And Company: Company Snapshot (2022) 265
11.1.7 Eppendorf Se 267
Table 278 Eppendorf Se: Company Overview 267
Figure 35 Eppendorf Se: Company Snapshot (2022) 268
11.1.8 Corning Incorporated 270
Table 279 Corning Incorporated: Company Overview 270
Figure 36 Corning Incorporated: Company Snapshot (2022) 271
11.1.9 Bio-Rad Laboratories, Inc. 273
Table 280 Bio-Rad Laboratories, Inc.: Company Overview 273
Figure 37 Bio-Rad Laboratories, Inc.: Company Snapshot (2022) 274
11.1.10 Takara Bio Inc. 278
Table 281 Takara Bio Inc.: Company Overview 278
Figure 38 Takara Bio Inc.: Company Snapshot (2022) 279
11.1.11 Fujifilm Holdings Corporation 282
Table 282 Fujifilm Holdings Corporation: Company Overview 282
Figure 39 Fujifilm Holdings Corporation: Company Snapshot (2022) 283
11.1.12 Getinge Ab 288
Table 283 Getinge Ab: Company Overview 288
Figure 40 Getinge Ab: Company Snapshot (2022) 289
11.1.13 Terumo Corporation 291
Table 284 Terumo Corporation: Company Overview 291
Figure 41 Terumo Corporation: Company Snapshot (2022) 292
11.1.14 Bio-Techne Corporation 294
Table 285 Bio-Techne Corporation: Company Overview 294
Figure 42 Bio-Techne Corporation: Company Snapshot (2022) 295
11.1.15 Himedia Laboratories Pvt. Ltd. 299
Table 286 Himedia Laboratories Pvt. Ltd.: Company Overview 299
11.2 Other Players 301
11.2.1 Stemcell Technologies, Inc. 301
11.2.2 Miltenyi Biotec Gmbh 301
11.2.3 Promocell 302
11.2.4 Anterogen Co. Ltd. 302
11.2.5 Cellgenix Gmbh 303
11.2.6 Pluristem Therapeutics Inc. 303
11.2.7 Daiichi Sankyo 304
11.2.8 Organogenesis Holdings Inc. 304
11.2.9 Vericel Corp. 305
11.2.10 American Cryostem Corp. 305
(Business Overview, Products Offered, Recent Developments, And Mnm View (Key Strengths/Right To Win, Strategic Choices Made, And Weaknesses And Competitive Threats))*

12 Appendix 306
12.1 Knowledgestore: Marketsandmarkets’ Subscription Portal 309
12.2 Customization Options 311
12.3 Related Reports 311
12.4 Author Details 312

  • Global Animal Stem Cell Therapy Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 89
    Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing The sample to concentrate The stem cells. Finally, The therapy includes transferring The stem cells into The injured site ......
  • Global Mesenchymal Stem Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 104
    According to our LPI (LP Information) latest study, the global Mesenchymal Stem Cells market size was valued at US$ 202.6 million in 2023. With growing demand in downstream market, the Mesenchymal Stem Cells is forecast to a readjusted size of US$ 278.8 million by 2030 with a CAGR of 4.7% during review period. The research report highlights the growth potential of the global Mesenchymal Stem Cells market. Mesenchymal Stem Cells are expected to show stable growth in the future market. How......
  • Global Stem Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Stem Cells market size was valued at US$ 2693.1 million in 2023. With growing demand in downstream market, the Stem Cells is forecast to a readjusted size of US$ 5700.6 million by 2030 with a CAGR of 11.3% during review period. The research report highlights the growth potential of the global Stem Cells market. Stem Cells are expected to show stable growth in the future market. However, product differentiation, reducing costs......
  • Global Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Stem Cell Therapy market size was valued at US$ 469.1 million in 2023. With growing demand in downstream market, the Stem Cell Therapy is forecast to a readjusted size of US$ 1724 million by 2030 with a CAGR of 20.4% during review period. The research report highlights the growth potential of the global Stem Cell Therapy market. Stem Cell Therapy are expected to show stable growth in the future market. However, product differ......
  • Global Animal Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Animal Stem Cell Therapy market size was valued at US$ 199.3 million in 2023. With growing demand in downstream market, the Animal Stem Cell Therapy is forecast to a readjusted size of US$ 476.2 million by 2030 with a CAGR of 13.2% during review period. The research report highlights the growth potential of the global Animal Stem Cell Therapy market. Animal Stem Cell Therapy are expected to show stable growth in the future ma......
  • Global Stem Cell Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Stem Cell market: According to our latest research, the global Stem Cell market looks promising in the next 5 years. As of 2022, the global Stem Cell market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells. ......
  • Global Animal Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Animal Stem Cell Therapy market size was valued at USD 209.7 million in 2023 and is forecast to a readjusted size of USD 469.9 million by 2030 with a CAGR of 12.2% during review period. Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or di......
  • Global Hematopoietic Stem Cells Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Hematopoietic Stem Cells market: According to our latest research, the global Hematopoietic Stem Cells market looks promising in the next 5 years. As of 2022, the global Hematopoietic Stem Cells market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Global Adipose Stem Cells (ASCS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Adipose Stem Cells (ASCS) market: According to our latest research, the global Adipose Stem Cells (ASCS) market looks promising in the next 5 years. As of 2022, the global Adipose Stem Cells (ASCS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs